Abstract. Treatment of skeletal muscle loss due to trauma or tumor ablation therapy still lacks a suitable clinical approach. Creation of functional muscle tissue in vitro using the differentiation potential of human satellite cells (myoblasts) is a promising new research field called tissue engineering. Strong differentiation stimuli, which can induce formation of myofibers after cell expansion, have to be identified and evaluated in order to create sufficient amounts of neo-tissue. The objective of this study was to determine the influence of static magnetic fields (SMF) on human satellite cell cultures as one of the preferred stem cell sources in skeletal muscle tissue engineering. Experiments were performed using human satellite cells with and without SMF stimulation after incubation with a culture medium containing low [differentiation medium (DM)] or high [growth medium (GM)] concentrations of growth factors. Proliferation analysis using the alamarBlue ® assay revealed no significant influence of SMF on cell division. Real-time RT-PCR of the following marker genes was investigated: myogenic factor 5 (MYF5), myogenic differentiation antigen 1 (MYOD1), myogenin (MYOG), skeletal muscle α1 actin (ACTA1), and embryonic (MYH3), perinatal (MYH8) and adult (MYH1) skeletal muscle myosin heavy chain. We detected an influence on marker gene expression by SMF in terms of a down-regulation of the marker genes in cell cultures treated with SMF and DM, but not in cell cultures treated with SMF and GM. Immunocytochemical investigations using antibodies directed against the differentiation markers confirmed the gene expression results and showed an enhancement of maturation after stimulation with GM and SMF. Additional calculation of the fusion index also revealed an increase in myotube formation in cell cultures treated with SMF and GM. Our findings show that the effect of SMF on the process of differentiation depends on the growth factor concentration in the culture medium in human satellite cultures. SMF alone enhances the maturation of human satellite cells treated with GM, but not satellite cells that were additionally stimulated with serum cessation. Therefore, further investigations are necessary before consideration of SMF for skeletal muscle tissue engineering approaches.
Introduction
Generation of functional muscle tissue in vitro using the regenerative potential of stem cells is the ambitious objective of skeletal muscle tissue engineering. The surgical treatment of large muscle defects still represents a demanding practice due to the difficulty of obtaining sufficient amounts of substitute tissue for functional restoration. Thus, in this context, tissue engineering is an encouraging option.
Satellite cells, also called myoblasts, are currently one of the preferred stem cells for skeletal muscle tissue engineering applications, because they can easily be harvested from muscle biopsies, have been extensively characterized, and show a stable differentiation potential into multinucleated myofibers (1) . However, it still remains a challenging procedure to induce a perpetual maturation process in expanded satellite cell cultures, a prerequisite to generate sufficient amounts of 'neotissue' for subsequent autologous transplantation. To overcome this obstacle it is important to develop potent differentiation techniques, which should be feasible for a later clinical application, i.e. the absence of possible mutagenic substances or methods that bear long-term risks (e.g. Matrigel ® ). Static magnetic fields (SMF) with an intensity of 80±5 mT have been shown to promote myogenic cell differentiation in the immortal rat cell line L6 in terms of increased accumulation of actin and myosin and formation of large multinucleated myotubes (2) . SMF are easily applicable in a cell culture setting and are not genotoxic or oncogenic and therefore, would be practical in clinical applications for skeletal muscle tissue engineering (3) . However, it remains unclear whether SMF have an effect on gene expression in myoblasts. Thus, the objective of this study was to analyze the effect of SMF on human satellite cell cultures regarding proliferation and differentiation.
To decipher the effect of SMF on gene expression, we performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) of well-defined marker genes in human satellite cell cultures treated with medium containing a low concentration of growth factors [differentiation medium (DM)]. Satellite cells treated with a medium containing higher amounts of growth factors [growth medium (GM)] served as the control.
Recent data demonstrate that the reference genes, peptidylprolyl isomerase A (cyclophilin A, PPIA) and the normalization factor (NF) calculated by the geNorm software are suitable endogenous control genes for relative gene quantification profiling studies in human myoblast cell cultures treated with SMF (4). Hence, all qRT-PCR were normalized with the NF.
In addition we used marker genes to identify early stages of muscle development, i.e. myogenic factor 5 (MYF5), myogenic differentiation antigen 1 (MYOD1), and myogenin (MYOG), factors of the myogenic regulator factor (MRF) family, which act as promoters of multiple muscle-specific genes that control the fusion of mononucleated myoblasts into multinucleated myofibers (5) . MYF5 enhances muscle cell proliferation and regulates skeletal muscle commitment of myoblasts (6) . MYOD1, the myogenic determination factor, is up-regulated during the early stages of myogenesis and promotes cell cycle withdrawal and induction of myoblast differentiation. MYOG is up-regulated during later stages of myogenesis than MYOD1 and acts more specifically during the development of multinucleated myofibers (7) . Thus, these genes can be used as distinct markers of differentiation.
One of the most abundant proteins in a mature myotube is the myosin heavy chain (MYH) that exists in various isoforms and accounts for muscle contraction. MYHs are used to characterize the different existing muscle fibers in mature skeletal muscle tissue due to the fact that each fiber type contributes to a variety of functional capabilities (8) . Additionally, during myogenesis different developmental isoforms of MHCs [embryonic (MYH3), perinatal (MYH8) and adult (MYH1)] exist, which can be used as indicators for maturation. Moreover, in vitro experiments with weak SMF (0-200 µT) have shown to accelerate Ca 2+ /calmodulin-dependent myosin light chain phosphorylation (9, 10) , and moderate-intensity of SMF (20 mT) stimulation on the rat diaphragm muscle revealed specific changes on ion transporters, which induced bioelectrical and biomechanical alterations (10) .
Furthermore, it has recently been demonstrated that SMF stimulation results in actin accumulation in cultured cells and leads to an increase in actin content in myotubes (2), as well as to hypertrophy. In this context it is of high interest to analyze the effect of SMF on the expression of the gene and protein α1 actin (ACTA1) as part of the contractile apparatus in skeletal muscles, which can act as a differentiation marker for the final stage of myogenesis. Therefore, we performed qRT-PCR of human myoblast cell cultures treated with GM or DM for 1, 4, 8, 12 and 16 days to examine the expression of the genes of interest (GOI), MYF5, MYOG, MYH1, MYH3, MYH8 and ACTA1, with or without SMF stimulation with the intensitiy of 80 mT generated by custom-made magnets.
This study presents data about the effects of SMF on proliferation, and gene and protein expression in human satellite cell cultures after identification and verification of valid reference genes, which may be of interest for skeletal muscle tissue engineering approaches.
Materials and methods
Cell culture. The study protocol was approved by the Ethics Committee of the Medical Faculty Mannheim of the University of Heidelberg, Germany. All patients gave informed written consent. Muscle tissue from 15 patients was harvested during head and neck surgery. Myoblasts (satellite cells) were extracted from minced muscle tissues by digestion with collagenase B (Roche, Mannheim, Germany) for 60 min and 0.05% trypsin-0.02% EDTA (PromoCell, Heidelberg, Germany) for 45 min at 37˚C, filtered by a sterile 70 µm cell strainer (BectonDickinson, Franklin Lakes, NJ, USA), and purified with the pre-plating technique (11) . Primary myoblasts were pooled from the 15 donors and expanded until passage three. Purity of myoblast cultures (>80%) was evaluated by anti-desmin immunostaining. Cells were grown in 0.2% gelatine-coated culture flasks (Sigma, Deisenhofen, Germany) in Ham's F-10 growth medium, containing 1% penicillin/streptomycin/ fungizone solution (PSF), 2 mM L-glutamine (PromoCell) and 10% fetal bovine serum (FBS; PAA Laboratories, Linz, Austria). This medium is referred to as growth medium (GM). Satellite cells were induced to differentiate by incubation with differentiation medium (DM) consisting of minimal essential medium (PromoCell) supplemented with 2% horse serum (PAA Laboratories), 2 mM L-glutamine, and PSF (PromoCell). GM and DM were changed every 72 h, and cells were cultured at 37˚C in a humidified atmosphere of 5% CO 2 and 95% air for 1, 4, 8, 12 or 16 days.
SMF exposure. SMF were produced by 4x4 cm neodymium magnetic plaques with a magnetic field of 80±5 mT, verified by a gaussmeter. The magnetic plaques were placed underneath the culture dishes with 1 mm distance from the cell monolayer culture as described by Coletti et al (2) . The magnetic fields were axial with the magnetic North vector crossing the cells (the pole of the magnet which would be repulsed by the Earth's North magnetic pole). Control samples were simultaneously grown and induced to differentiate in identical experimental conditions without the presence of SMF. Magnets did not produce temperature variation. Immunocytochemistry. Immunocytochemical characterization was carried out with cells grown on chamber culture slides (Falcon, BD Biosciences, Franklin Lakes, NJ). To indicate the differentiation of myoblasts, the cells were incubated with antibodies directed against: desmin (1:100; Dako, Hamburg, Germany), MYF5, MYOG (1:50; both from Santa Cruz Biotechnology, Heidelberg, Germany), MYH1 (1:20; Santa Cruz Biotechnology), MYH8 (1:40; Abcam, Cambridge, UK) or ACTA1 (1:50; Zymed Laboratories, Invitrogen, Karlsruhe, Germany) followed by the use of a corresponding biotinylated secondary antibody and a streptavidin-biotin horseradish peroxidase complex. The peroxidase reaction was visualized using aminoethylcarbazol (Dako) as a chromogen. For negative controls, the first antibody was omitted. Endogenous peroxidase was blocked with 0.3% hydrogen peroxide (30 min). Sections were washed with PBS and incubated with normal sheep serum in PBS (30 min, room temperature) to block the non-specific antibody reaction. Cells of five randomly selected fields were counted and averaged independently by two investigators. Nuclei were counterstained with Harris hematoxylin. Light microscopic investigations were performed using a Zeiss Axiophot microscope (Carl Zeiss, Jena, Germany).
Fusion index determination.
To quantify differentiation, the number of nuclei in ACTA1, MYH1 or MYH8 positive myotubes was counted and expressed as percentage of the total number of nuclei analyzed. The fusion index (FI) was determined on Days 4, 8, 12 and 16 of culture by dividing the number of nuclei in ACTA1-, MYH1-or MYH8-positive myotubes (with two or more nuclei) by the total number of nuclei x100.
RNA isolation. Total-RNA was isolated using the RNeasy mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. RNA concentration and purity were determined by A260 and A280 (A260/A280 = 1.7-2.0) measurements using a NanoDrop 8000 spectrophotometer (Thermo Scientific, Schwerte, Germany). Integrity was analyzed by an Agilent 2100 Bioanalyzer (Stratagene-Agilent Technologies, Waldbronn, Germany).
cDNA synthesis and real-time PCR. An aliquot of 0.5 µg total-RNA was treated with 1 unit DNase (Fermentas, St. Leon-Rot, Germany) for 30 min at 37˚C. Reverse transcription of RNA (0.5 µg) was performed with oligo(dt) [12] [13] [14] [15] [16] [17] [18] primer, 200 units of SuperScript II (Invitrogen) and 24 units of RiboLock™ RNase inhibitor (Fermentas) for 1 h at 42˚C. The cDNA was used for qRT-PCR analysis. All cDNA probes were analyzed for genes of interest: MYF5, NM_005593; MYOG, NM_002479; ACTA1, NM_001100; MYH1, NM_005963; MYH3, NM_002470; MYH8, NM_002472. Moreover, the following reference genes (RG) were investigated: β-actin (ACTB), NM_001101; β-2-microglobulin (B2M), NM_004048; glyceraldehyde-3-phosphate dehydrogenase (GAPDH), NM_002046; cyclophilin A (PPIA), NM_203430; large ribosomal protein P0 (RPLP0), NM_001002; TATA box binding protein (TBP), NM_003194. The QuantiTect/Primer assays were purchased from Qiagen. The cDNAs were amplified with Brilliant ® II SYBR ® -Green qRT-PCR Master mix (Stratagene-Agilent Technologies). The thermal profile consisted of 1 cycle at 50˚C for 2 min followed by 1 cycle at 95˚C (2 min), 45 cycles at 95˚C (15 sec), 60˚C (1 min). Amplification was performed using the Mx3005P™ qPCR System (Stratagene-Agilent Technologies). For relative quantification, a standard curve was generated in every individual run. Total-RNA was pooled from muscle biopsies of healthy human volunteers. Reverse transcription was performed, and a serial dilution of the cDNA was used to perform the calibration curve. The data was analyzed using the relative standard curve method. For each unknown sample, the relative amount was calculated using linear regression analysis from their respective standard curves. Data were analyzed using Mx3005P analysis software. The efficiencies of all GOI and those of the RGs were calculated in every individual run. Evaluations were performed on Days 1, 4, 8, 12, 16 and 21 by qRT-PCR (in duplicate) in satellite cell cultures nourished with DM and GM and stimulated with or without SMF. Expression results are shown from four independent experiments.
Analysis of expression stability. The qRT-PCR data were analyzed using the Mx3005P™ qPCR system. To compare the stability of six candidate reference genes within sample groups, the software geNorm (12) version 3.4 (Visual Basic application tool for Microsoft Excel) was used according to developer's recommendations.
geNorm uses a gene-stability measurement M, which is defined as the average pairwise variation between a particular gene and all other control genes. It calculates the optimal number of genes necessary for normalization of a target gene and combines them into a NF as previously described by our group and others (4, 12, 13) .
Statistical analyses. The software Sigma Plot was used to carry out statistical analyses by the paired Student's t-test or the Mann-Whitney U test, as well as the Pearson's product correlation test of gene expression among experimental groups. Gene expression results are shown as the mean. A P-value <0.05 was considered statistically significant.
Results

Proliferation.
As expected, cell cultures treated with GM revealed higher rates of proliferation than those treated with DM. This proliferation difference was particularly evident during the early days of cell culture. SMF application to human satellite cell cultures incubated with GM or DM did not significantly change the cell turnover, resulting in almost identical proliferation curves over time, irrespective of SMF treatment ( Fig. 1) .
DNA fragmentation. In cultured human satellite cells, with or without SMF treatment, incubated with GM or DM, apoptotic cells were not seen. These data indicate that SMF did not induce apoptosis at the investigated time points (Days 1, 4, 8, 16 and 21).
RNA quality. RNA samples were examined as to their concentration, purity, and integrity. RNA purity was measured using the NanoDrop ® spectrophotometer. Based on the absorbance ratio at 260/280 nm [mean ± standard deviation (SD), 1 expression was about 50% lower in comparison to the beginning, however the expression almost linearly increased until Day 12 to levels similar to the beginning, thereafter decreasing about 30% until Day 21. In myoblasts cultured with DM with SMF stimulation, MYOD1 expression was 1.6-to 1.7-fold higher (Days 4 and 8) compared to myoblasts at the beginning of the experiment (Day 0). Between Days 8 and 21 MYOD1 expression almost linearly decreased by ~65%. In myoblasts cultured with DM with SMF stimulation, MYOD1 expression was about 1.8-to 3.4-fold higher than in myoblasts cultured with DM but without SMF stimulation. Thereafter, at identical time points the MYOD1 expression was similar in myoblasts under differentiation conditions with or without SMF stimulation. In myoblasts cultured with GM without SMF stimulation (GM-SMF), MYOD1 expression was 1.7-to 3. Immunocytochemistry. In order to validate the measured mRNA expression and detect possible differences with the corresponding protein levels immunocytochemical staining was performed using monoclonal antibodies directed against MYF5, MYOG, MYH8, MYH1 and ACTA1 (Table I) Immunocytochemical characterization of cultured human myoblasts is representatively shown in Fig. 3 : on Day 12, anti-MYH8 staining in cultured human satellite cells incubated with GM, demonstrated cytoplasmic (thick filaments of the myofibrils) localization of MYH8 in elongated, multinucleated myotubes. Stronger distribution was found after stimulation with SMF ( Fig. 3A and B) .
Anti-MYH1 staining of cultured (on Day 12) human myoblasts incubated with GM, showed MYH1 in elongated, multinucleated myotubes. Again more positive cells were found after stimulation with SMF ( Fig. 3C and D) .
Anti-ACTA1 staining of cultured (on Day 12) human satellite cells incubated with GM showed an enhanced cytoplasmic distribution pattern of the immunoreaction after stimulation with SMF ( Fig. 3E and F) .
Fusion index.
To evaluate the impact of SMF on human satellite cell cultures, an additional, independent and well-accepted method was used, i.e. the fusion index was calculated in forming myotubes expressing ACTA1 and MYH1 at different time points with or without SMF stimulation (Fig. 4) . In satellite cells cultured with GM, the fusion index of ACTA1-and MYH1-positive myotubes showed a time-dependent increase with the highest level on Day 21. SMF significantly increased the fusion index of both differentiation markers ACTA1 and MYH1 during all time points of observation in comparison to non-stimulated cells cultured with GM. In DM-nourished cells the fusion index of MYH1 and ACTA1 also increased with time in satellite cells without SMF stimulation, except for ACTA1 on Day 12. After stimulation with SMF no significant difference in the fusion index of ACTA1-positive myotubes was detected in cells cultured with DM. On the contrary, the MYH1 fusion index was higher after stimulation with SMF with a time-dependent increase.
The ACTA1 fusion index showed a time-dependent increase indicating the differentiation of satellite cell cultures nourished with GM with or without SMF stimulation, but in DM treated cultures with or without SMF stimulation the ACTA1 fusion index remained almost at a constant level between 0.1 and 0.2.
SMF stimulation in GM or DM cultured myoblasts resulted in a constant augmentation of the MYH1 fusion indices with time, however the fusion indices were higher in DM-treated cultures at all examined time-points in comparison to GM-nourished myoblasts.
Discussion
Identification of strong and clinically applicable differentiation stimuli that can induce the fusion of mononucleated myoblasts into multinucleated myofibers is one important prerequisite to clinical utilization for the emerging field of skeletal muscle tissue engineering. Various stimuli, (e.g. neuronal co-cultivation, gene transfer methods, sarcoma extract Matrigel ® ) have been investigated in terms of their differentiation potential, but all lack clinical feasibility due to unpredictable risks for the patients (1) .
SMF generated by magnets have been shown to promote myogenic cell differentiation and hypertrophy in the immortal L6 rat skeletal muscle cells in terms of increased accumulation of actin and myosin, both proteins of the contractile apparatus (2). Additionally, formation of larger myotubes was observed by others after treatment with 80 mT magnetic fields. Furthermore, Table I . Immunocytochemical evaluation of muscle-specific differentiation marker proteins in human satellite cells cultured in growth medium or differentiation medium with or without static magnetic field stimulation from Day 4 until 21. an accelerated differentiation in myoblasts stimulated with a 50 mT magnetic field was described, when microparticles were introduced into the cytoplasm (14) . Additionally, the authors report that differentiation marker expression was detectable at early time points in myoblasts containing the micro particles after SMF stimulation. SMF are already frequently applied on human skeletal muscles for musculoskeletal pain relief and until now no oncogenic or genotoxic effects were observed in living cells (3) . Based on these observations, we investigated the impact of SMF as a differentiation stimulus on human satellite cells regarding proliferation and gene and protein expression in human satellite cell cultures incubated with a medium containing low concentration of growth factors (DM) with or without SMF treatment. Human satellite cells incubated with a medium containing high amounts of growth factors (GM) with or without SMF stimulation served as a control group, since differentiation of skeletal myoblasts in cultures is negatively regulated by growth factors in the serum, indicating that signaling pathways induced by growth factors present in serum will facilitate myoblast proliferation but inhibit myogenesis (6) . Proliferation analysis using the alamarBlue ® assay revealed no differences between human satellite cells with or without SMF stimulation, independent from the growth factor concentration in the culture medium, supporting the data of others showing that SMF does not significantly affect cell proliferation of myoblasts (2) . These data are supported by the fact that apoptotic cells were not seen after stimulation with SMF. In general, it is noteworthy to mention that the effect of SMF on cell proliferation seems to be inversely proportional to the strength of the magnetic field. Furthermore, it has been reported that prolonged exposure to the strong magnetic field of 7 mT inhibits the growth of the human tumor cell lines HTB63 (melanoma), HTB 77IP3 (ovarian carcinoma) and CCL86 (lymphoma) (3, 15) . Thus, the effect of SMF varies depending on the cell type and strength of the magnetic field. As expected, satellite cell cultures treated with GM showed higher proliferation rates in the beginning in comparison to satellite cells nourished with DM, which can be explained by the different concentrations of growth factors in the culture media. High concentrations of growth factors will facilitate myoblast proliferation, but inhibit differentiation (6) .
Staining pattern
Satellite cell differentiation is initiated by an up-regulation of the myogenic regulator protein MYF5, which is necessary for proliferation and specialization followed by a downregulation with the ongoing differentiation process (16) and can therefore be used as an early marker of myogenesis. We observed no significant effect of SMF stimulation on MYF5 expression in human satellite cell cultures. All groups showed a peak expression of MYF5 on Day 4, followed by consecutive declines, supporting the assumption of the beginning of differentiation of all cells and verifying the myogenic cell line character. Additionally, our gene expression results were confirmed by the protein expression of MYF5 underlying the high degree of accuracy. Therefore, it is suggested that SMF does not inhibit differentiation and proliferation during the early course of myogenesis.
MYOD1, a transcription factor which promotes several muscle specific genes by heterodimerization with 'E-proteins' and binding to the DNA-sequence CANNTG, induces differentiation by withdrawal of the cell-cycle both by cross-talking with the cell cycle regulators (6) and by inhibiting cytokine signals (17) . The up-regulation of MYOD1 represents the start of the myogenic differentiation process. In cell cultures nourished with GM, we found a time-dependent increase until Day 16 in cells with SMF stimulation, myoblasts without SMF stimulation showed a 2.4-to 2.8-fold higher expression of MYOD1 with a peak expression on Day 12. In human satellite cell cultures treated with DM and SMF, higher concentrations of MYOD1 were measured by qRT-PCR until Day 8, followed by similar expression levels in comparison to cells without SMF stimulation and cultured with DM. In summary, SMF appears to have a mild amplification effect on MYOD1 gene expression during the early courses of myogenesis if human myoblast cells are additionally stimulated by serum cessation. This effect is not evident if cell cultures are cultured with a medium containing high concentrations of growth factors (GM), indicating that the influence of SMF on the MYOD1 expression highly depends on growth factor concentration.
The gene expression results of MYOG, a member of the MRF family, which acts later and more specifically during the development of myofibrils (18) showed a time-dependent increase with the ongoing differentiation in myoblasts cultured in GM, but no evident effect of the SMF stimulation. Interestingly, myoblasts cultured with DM also showed a time-dependent up-regulation with the advancing process of maturation, but lower MYOG gene expression was detected after the stimulation with SMF. In our study, this effect was verified by immunocytochemical investigations, also showing a lower amount of MYOG-positive cells in SMF-stimulated myoblasts after culture with DM. This finding is in contrast to the data of Coletti et al (2) , who detected no differences in the MYOG gene expression between SMF-stimulated and nonstimulated L6 cells despite the enhancing maturation. This discrepancy may be explained by the different origin of the cells examined, i.e. an immortal cell line vs. primary human cells, additionally highlighting the importance to utilize primary human cells for tissue engineering research.
MYHs are of the most abundant proteins in a mature myotube, existing in various isoforms, which can be used to characterize fiber type and developmental status (19) . During myogenesis, the MYH3 and a MYH8 isoforms can be detected in developing myofibers and therefore, can be used as indicators for maturation (16) . In our study, in almost all groups, the embryonic-MYH3 showed a constant increase in concentration as the number of myotubes increased. In satellite cells cultured with GM and SMF stimulation, no substantial differences were observed concerning the MYH3 gene expression. In cell cultures nourished with DM, SMF stimulation led to a decrease of the mRNA concentration at all time points examined until Day 21. This SMF-dependent effect on human satellite cells could also be found concerning the expression of the perinatal-isoform MYH8, which showed decreased mRNA concentrations after SMF stimulation in comparison to cells without SMF stimulation. In myoblasts cultured with GM no amplification effect of the SMF was seen on the gene expression level, but the immunocytochemical staining revealed an increase of MYH8-positive cells after stimulation with SMF. The adult isoform MYH1 was also suppressed after SMF stimulation in myoblsats cultured with DM. This effect was not seen in human satellite cells nourished with GM. The data about the gene expression of the different isoforms of the MYH genes indicate that SMF can suppress an up-regulation in the gene expression and therefore, inhibit differentiation after SMF stimulation if myoblasts are cultured with DM. This effect was not detected in cells cultured with GM, where differences after SMF stimulation were detected. This finding supports the hypothesis that the effect of SMF on the gene expression in human satellite cells depends on the growth factor concentration. The effect of SMF on the expression at the protein level (evaluated by immunocytochemistry) showed an enhancement of MYH-expression in the cells stimulated with GM and SMF and not in cells nourished with DM, i.e. the degree of impact on cell physiology depends on the growth factor concentration in the culture medium. In vitro experiments on skeletal muscle could show that DC-generated SMF in the range of 0-200 µT accelerates Ca 2+ /calmodulin-dependent myosin light chain phosphorylation and therefore, influences physiological properties on the contractile apparatus (9) .
The ACTA1 gene encodes skeletal muscle α-actin, which is a major constituent of the contractile apparatus and along with myosin, is essential for muscle contractions (20) . Therefore, ACTA1 expression can be used as a marker of the final stages during myogenesis (21) . Our study shows that ACTA1 expression in human satellite cell cultures nourished with DM was decreased after SMF stimulation, indicating a lower degree of maturation after SMF stimulation. In cell cultures nourished with GM this effect was not observed.
According to our immunocytochemical data, we calculated the fusion index as a gene-independent marker of differentiation in ACTA1-or MYH1-positive human satellite cell cultures, showing a statistically significant increase of the fusion index of both differentiation markers after incubation with GM and SMF stimulation. Our findings provide evidence that SMF stimulation enhances maturation of human myoblasts/satellite cells when being incubated with high concentration of growth factors. Interestingly, this effect was not followed by an up-regulation of the examined marker genes. However, a suppression of the marker genes, as detected in satellite cells nourished with DM was not observed. This effect was not seen in human myoblasts, which were stimulated to differentiate by growth factor cessation, giving evidence that the effect of SMF depends on the growth factor concentration in the culture medium. However, the underlying mechanisms of the differentiation process remain unknown to date and will be the subject of further investigations.
In conclusion, we observed a suppression of well-defined marker genes in cultured human myoblasts after stimulation with SMF of 80 mT using qRT-PCR with internationally-accepted reference genes for cells incubated in DM. However, SMF enhances the maturation of cultured human satellite cells cultured with GM, indicating that the effect of SMF depends on the growth factor concentration in the culture medium. Therefore, further investigations are necessary before consideration of SMF for skeletal muscle tissue engineering approaches.
